Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Miles

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2016
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung CancerDavid B Landau, Laura Hughes, Angela Baker, et al.
European Urology|October 8, 2024
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled TrialRobert Huddart, Shaista Hafeez, Clare Griffin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancerSarah M Kelly, Rachel Effeney, Mark N Gaze, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
BMJ Open|February 26, 2025
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Eleanor Mae Hudson, Florien W Boele, et al.
Clinical and Translational Radiation Oncology|December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancerDavid J Thomson, Clare Cruickshank, Helen Baines, et al.
JCO Global Oncology|July 9, 2026
Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning AssistantTucker J Netherton, Ajay Aggarwal, Qusai Alakayleh, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2019
Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung CancerJohn D Fenwick, David B Landau, Angela T Baker, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2016
IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung CancerDavid B Landau, Laura Hughes, Angela Baker, et al.
European Urology|October 8, 2024
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled TrialRobert Huddart, Shaista Hafeez, Clare Griffin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 3, 2022
QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancerSarah M Kelly, Rachel Effeney, Mark N Gaze, et al.
BMJ Open|December 3, 2021
POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodesAmit Goyal, G Bruce Mann, Lesley Fallowfield, et al.
BMJ Open|February 26, 2025
APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Eleanor Mae Hudson, Florien W Boele, et al.
Clinical and Translational Radiation Oncology|December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancerDavid J Thomson, Clare Cruickshank, Helen Baines, et al.
JCO Global Oncology|July 9, 2026
Artificial Intelligence-Powered Radiotherapy for Resource-Limited Settings: Advancing Cervical and Prostate Cancer Treatment Planning With the Radiation Planning AssistantTucker J Netherton, Ajay Aggarwal, Qusai Alakayleh, et al.
Pageof 5